Role of glial glutamate transporters in the facilitatory action of FK960 on hippocampal neurotransmission.

[1]  N. Matsuoka,et al.  FK960, a novel potential anti-dementia drug, enhances high K+-evoked release of somatostatin from rat hippocampal slices , 2001, Brain Research.

[2]  T. Nishizaki,et al.  Sustained facilitatory action of FK960 on hippocampal neurotransmission , 2000, Brain Research.

[3]  N. Matsuoka,et al.  FK960, a novel potential anti-dementia drug, augments long-term potentiation in mossy fiber-CA3 pathway of guinea-pig hippocampal slices , 1998, Brain Research.

[4]  J. Rothstein,et al.  Glutamate Transporter Protein Subtypes Are Expressed Differentially during Rat CNS Development , 1997, The Journal of Neuroscience.

[5]  T. Aigner,et al.  FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine. , 1997, The Journal of pharmacology and experimental therapeutics.

[6]  N. Matsuoka,et al.  FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action. , 1996, The Journal of pharmacology and experimental therapeutics.

[7]  R. Fremeau,et al.  Characterization and distribution of the neuronal glutamate transporter EAAC1 in rat brain. , 1996, The American journal of physiology.

[8]  T. Marunouchi,et al.  Expression of glutamate transporters in cultured glial cells , 1995, Neuroscience Letters.

[9]  A. Levey,et al.  Localization of neuronal and glial glutamate transporters , 1994, Neuron.

[10]  N. Matsuoka,et al.  Role of somatostatin in the augmentation of hippocampal long-term potentiation by FR121196, a putative cognitive enhancer. , 1993, European journal of pharmacology.

[11]  S. Kaneko,et al.  Somatostatin augments long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampal slices , 1991, Brain Research.